The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis.

@article{Hong2016TheSI,
  title={The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis.},
  author={Ho Cheol Hong and Soon Young Hwang and Ja Young Ryu and Hye Jin Yoo and Ji A Seo and Sin Gon Kim and Nan Hee Kim and Sei Hyun Baik and Dong Seop Choi and Kyung Mook Choi},
  journal={Clinical endocrinology},
  year={2016},
  volume={84 2},
  pages={
          203-209
        }
}
OBJECTIVE Nonalcoholic fatty liver disease (NAFLD) is a well-known contributor for the development of cardiovascular disease (CVD). We examined the influence of NAFLD and metabolic syndrome (MetS) on markers of subclinical atherosclerosis, including carotid intima-media thickness (CIMT), brachial-ankle pulse wave velocity (baPWV) and ankle-brachial pressure index (ABI), after adjusting for cardiometabolic risk factors. DESIGN A cross-sectional study. PATIENTS AND MEASUREMENTS The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Similar Papers

Loading similar papers…